Clinical trial
Study of Cancer Stem Cell Vcccinie That as a Specific Antigen in Metastatic Adenocarcinoma of the Breast
NCT02063893 is registered in ClinicalTrials.gov with Fuda Cancer Hospital, Guangzhou as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of Cancer Stem Cell Vcccinie That as a Specific Antigen in Metastatic Adenocarcinoma of the Breast
- Lead sponsor
- Fuda Cancer Hospital, Guangzhou
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2014
- Completion date
- February 28, 2015
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
neoplasms, breast